Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects Aged 9 to 60 Years in the Philippines
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 04 Jul 2017
At a glance
- Drugs CYD TDV (Primary) ; DTaP vaccine (Primary)
- Indications Dengue
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors sanofi pasteur
- 28 Jun 2017 Planned End Date changed from 1 Mar 2019 to 2 Jan 2019.
- 28 Jun 2017 Planned primary completion date changed from 1 Mar 2019 to 2 Jan 2019.
- 28 Jun 2017 Status changed from not yet recruiting to active, no longer recruiting.